These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11364773)

  • 1. Agencies revise guidelines for IDU transmissions. U.S. Department of Health and Human Services.
    AIDS Alert; 1997 Nov; 12(11):suppl 1-2. PubMed ID: 11364773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A duty to care: sterile injection equipment and illicit-drug use.
    Novick A
    AIDS Public Policy J; 1996; 11(2):63-5. PubMed ID: 10915239
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of needle exchange programs in HIV prevention.
    Vlahov D; Junge B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted, community-level HIV prevention program.
    Rietmeijer CA; Kane MS; Simons PZ; Corby NH; Wolitski RJ; Higgins DL; Judson FN; Cohn DL
    AIDS; 1996 Mar; 10(3):291-8. PubMed ID: 8882669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updating the infection risk reduction hierarchy: preventing transition into injection.
    Vlahov D; Fuller CM; Ompad DC; Galea S; Des Jarlais DC
    J Urban Health; 2004 Mar; 81(1):14-9. PubMed ID: 15047779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.
    Santibanez SS; Garfein RS; Swartzendruber A; Purcell DW; Paxton LA; Greenberg AE
    J Urban Health; 2006 Jan; 83(1):86-100. PubMed ID: 16736357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician prescribing of sterile injection equipment to prevent HIV infection: time for action.
    Burris S; Lurie P; Abrahamson D; Rich JD
    Ann Intern Med; 2000 Aug; 133(3):218-26. PubMed ID: 10906838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update: syringe-exchange programs--United States, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jun; 46(24):565-8. PubMed ID: 9221326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
    Weiss SH; Weston CB; Quirinale J
    AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.
    Estrada AL
    Public Health Rep; 2002; 117 Suppl 1(Suppl 1):S126-34. PubMed ID: 12435836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV prevention for injecting drug users: the first 25 years and counting.
    Des Jarlais DC; Semaan S
    Psychosom Med; 2008 Jun; 70(5):606-11. PubMed ID: 18519886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles.
    Gostin LO; Lazzarini Z; Jones TS; Flaherty K
    JAMA; 1997 Jan; 277(1):53-62. PubMed ID: 8980211
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.
    Strauss SM; Astone JM; Des Jarlais DC; Hagan H
    AIDS Patient Care STDS; 2005 Feb; 19(2):78-88. PubMed ID: 15716639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC gives communities prevention strategies. Centers for Disease Control and Prevention.
    AIDS Alert; 1999 Jun; 14(6):66. PubMed ID: 11366409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and intravenous drug users. Implications for emergency services.
    Kelen GD; Fleetwood D
    Emerg Med Clin North Am; 1990 Aug; 8(3):653-64. PubMed ID: 2201526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and HCV infection among injecting drug users.
    Hagan H; Des Jarlais DC
    Mt Sinai J Med; 2000; 67(5-6):423-8. PubMed ID: 11064493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the risk of HIV infection associated with illicit drug use.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2006 Feb; 117(2):566-71. PubMed ID: 16452382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.